Hong Kong to Ban E-Cigarettes in Public Places by 2026

Feb.11
Hong Kong to Ban E-Cigarettes in Public Places by 2026
Hong Kong to ban possession and use of e-cigarettes in public places starting mid-2026, aiming to protect youth from harm.

According to a report by 8World on February 10th, Hong Kong, China will soon ban the possession and use of e-cigarettes in public places starting in mid-2026.


Since April 2022, Hong Kong has banned the import, production, and sale of e-cigarettes, but they are still quite prevalent. The Director of Health of the Hong Kong Department of Health, Dr. Constance Chan, stated in a television program that, in order to protect young people, the authorities believe it is time to strengthen regulation of e-cigarettes.


According to Lu Chongmao, the government plans to first enact legislation to prohibit the possession and use of e-cigarettes in public places. After the public gradually adapts to this ban, it will be further expanded to more locations.


Lu Chongmao also pointed out that the authorities' goal is to submit the relevant policies to the Legislative Council for review in April this year. In addition, the Hong Kong SAR government has also proposed legislation to ban flavored tobacco products, such as mint and fruit-flavored cigarettes.


The Hong Kong Special Administrative Region government hopes to reduce the local smoking rate from 9.1% two years ago to 7.8% through a series of measures.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
In this in-depth contribution to 2Firsts, harm reduction expert Harry Shapiro exposes the misinformation and bias in global tobacco control, calling for evidence-based safer nicotine alternatives to protect public health and save lives.
Jul.08
Legal Analysis: Why SKE Lost the “CRYSTAL BAR” Trademark Case and Key Takeaways
Legal Analysis: Why SKE Lost the “CRYSTAL BAR” Trademark Case and Key Takeaways
Attorney Liu Peiling analyzed SKE’s loss in the “CRYSTAL BAR” trademark case, highlighting the UK’s “first-to-file” principle and common pitfalls in Chinese firms’ overseas IP strategies, such as delayed registration and weak evidence. She urged Chinese brands to plan trademark filings early and improve evidence retention to avoid disputes and protect their rights.
Jul.07 by 2FIRSTS.ai
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris International introduces new HNB product IQOS ILUMA i One in South Korea for $45.
Jun.12 by 2FIRSTS.ai
PMI Positions Indonesia as Key Asia-Pacific Hub to Drive Innovation and Export of New Tobacco Products
PMI Positions Indonesia as Key Asia-Pacific Hub to Drive Innovation and Export of New Tobacco Products
PMI and its Indonesian affiliate Sampoerna are investing $330 million (IDR 5.35 trillion) to build Southeast Asia’s first smoke-free product facility in Karawang, West Java. As PMI’s seventh global site for next-gen products, the plant includes Asia’s only advanced lab of its kind. It produces devices like IQOS and VEEV and has launched a localized BLENDS line, now available in 20 major Indonesian cities.
Jul.04 by 2FIRSTS.ai
New Zealand Government: Repeals Vaping Device Removability Rule, Disposable Vape Ban Remains in Effect
New Zealand Government: Repeals Vaping Device Removability Rule, Disposable Vape Ban Remains in Effect
New Zealand’s coalition government will revoke the requirement for all vaping devices, including heated tobacco products, to have removable batteries starting September 1, following a legal challenge by Mason Corporation, parent company of vape retailer Shosha. The decision does not affect the ban on disposable vaping devices, which came into effect on June 17.
Jul.24 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai